Author of

• 32210

  +

  EP1.15 - Thymoma/Other Thoracic Malignancies (ID 205)

  • Event: WCLC 2019
  • Type: E-Poster Viewing in the Exhibit Hall
  • Track: Thymoma/Other Thoracic Malignancies
  • Presentations: 1
  • Now Available
  • Moderators:
  • Coordinates: 9/08/2019, 08:00 - 18:00, Exhibit Hall

  • 32238

    +

    EP1.15-24 - Video-Assisted Thoracoscopy Approach for Radical Thymoma Resection (Now Available) (ID 1875)

    08:00 - 18:00  |  Author(s): Juan Manuel Corcoles Padilla
    • Abstract
    • Slides

    Background
    

    Thymoma is the most common neoplasm of the anterior mediastinum, accounting for 20-25% of all mediastinal tumors and 50% of anterior mediastinal masses. the mean age of patients is 52 years. No sexual predilection. The main treatment is complete surgical resection. Minimally invasive thymectomy (MIT) for thymic tumors remains good opcion in both early and advanced stages, minimizing surgical trauma, improving post-operative course and recovery and pain redusing.

    Method
    

    The aim of this study was to review our experience with VATS surgery for thymoma radical and extended resection. We reviewed data from all MIT cases from December 2009 to February 2019. Patients data was collected regarding demography, perioperative management and clinical outcomes.

    Result
    

    A total of 16 VATS thymectomies were performed in the last 10 years, from December 2009 to February 2019. The median age was 52 years ( range: 27 – 83 years) with fimale to male ratio of 1/,1,3.The main pathologic diagnosis was Thymoma and Thymic carcinoma (13%) with 5 % associated with myasthenia gravis (MG). The mean tumor size was 4,09 cm (range: 3 to 11 cm).

    Figure 1.CT- scan image showing a 11 cm giant anterior mediastinal Thymoma, successfully resected by 2 portal VATS access of the left hemithorax..

    Mean blood loss and operative time were significantly lower in the video-assisted thoracoscopic surgery versus open surgery.There was no 30-day mortality. Reoperation was not required. Lenght of hospital stay 3,5 days (range 2 -9 days). Mean follow up was 20 months, with no tumor recurrence.

    Conclusion
    

    Unilateral and bilateral VATS approaches have demonstrated good long-term oncologic and neurologic results with low complication rates. Reduced blood loss, operative time and earlier hospital discharge.

    Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.